PureTech Health plc (OTCMKTS:PTCHF – Get Free Report)’s share price was up 3.4% during mid-day trading on Thursday . The stock traded as high as $1.83 and last traded at $1.83. Approximately 200 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 7,040 shares. The stock had previously closed at $1.77.
PureTech Health Trading Up 3.4 %
The business’s 50 day simple moving average is $1.75 and its 200 day simple moving average is $1.90.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Recommended Stories
- Five stocks we like better than PureTech Health
- What Makes a Stock a Good Dividend Stock?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Top 3 Beverage Stocks Pouring Out Profits
- Earnings Per Share Calculator: How to Calculate EPS
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
